158 related articles for article (PubMed ID: 26850363)
1. Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains.
Muller N; Amiot A; Le Thuaut A; Bastuji-Garin S; Deforges L; Delchier JC
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):517-24. PubMed ID: 26850363
[TBL] [Abstract][Full Text] [Related]
2. A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients.
Gómez Rodríguez BJ; Castro Laria L; Argüelles Arias F; Castro Márquez C; Caunedo Álvarez Á; Romero Gómez M
Rev Esp Enferm Dig; 2017 Aug; 109(8):552-558. PubMed ID: 28617030
[TBL] [Abstract][Full Text] [Related]
3. New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.
Tursi A; Di Mario F; Franceschi M; De Bastiani R; Elisei W; Baldassarre G; Ferronato A; Grillo S; Landi S; Zamparella M; De Polo M; Boscariolo L; Picchio M
Helicobacter; 2017 Jun; 22(3):. PubMed ID: 28125857
[TBL] [Abstract][Full Text] [Related]
4. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
[TBL] [Abstract][Full Text] [Related]
5. Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori.
Delchier JC; Malfertheiner P; Thieroff-Ekerdt R
Aliment Pharmacol Ther; 2014 Jul; 40(2):171-7. PubMed ID: 24863854
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Malfertheiner P; Bazzoli F; Delchier JC; Celiñski K; Giguère M; Rivière M; Mégraud F;
Lancet; 2011 Mar; 377(9769):905-13. PubMed ID: 21345487
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pylori.
Nyssen OP; McNicholl AG; Gisbert JP
Helicobacter; 2019 Apr; 24(2):e12570. PubMed ID: 30767339
[TBL] [Abstract][Full Text] [Related]
8. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
[TBL] [Abstract][Full Text] [Related]
9. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection.
Dore MP; Graham DY; Mele R; Marras L; Nieddu S; Manca A; Realdi G
Am J Gastroenterol; 2002 Apr; 97(4):857-60. PubMed ID: 12003419
[TBL] [Abstract][Full Text] [Related]
10. Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.
Bago J; Pevec B; Tomić M; Marusić M; Bakula V; Bago P
Wien Klin Wochenschr; 2009; 121(1-2):47-52. PubMed ID: 19263014
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori infection with a new bismuth-based quadruple therapy in clinical practice.
Pérez-Arellano E; Rodriguez-Garcia MI; Galera Rodenas AB; de la Morena-Madrigal E
Gastroenterol Hepatol; 2018 Mar; 41(3):145-152. PubMed ID: 29054320
[TBL] [Abstract][Full Text] [Related]
13. Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori.
Lahaie R; Farley A; Dallaire C; Archambault A; Fallone CA; Ponich T; Hunt R; Oravec M; Whitsitt P; Van Zanten SV; Marcon N; Bailey R; Dumont A; Nguyen B; Desrochers S; Spénard J
Can J Gastroenterol; 2001 Sep; 15(9):581-5. PubMed ID: 11573100
[TBL] [Abstract][Full Text] [Related]
14. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of twice a day, bismuth-containing quadruple therapy using high-dose tetracycline and metronidazole for second-line Helicobacter pylori eradication.
Kim JY; Lee SY; Kim JH; Sung IK; Park HS
Helicobacter; 2020 Apr; 25(2):e12683. PubMed ID: 32074663
[TBL] [Abstract][Full Text] [Related]
16. Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Wong WM; Gu Q; Chu KM; Yee YK; Fung FM; Tong TS; Chan AO; Lai KC; Chan CK; Wong BC
Aliment Pharmacol Ther; 2006 Feb; 23(3):421-7. PubMed ID: 16423001
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori eradication in renal recipient: triple or quadruple therapy?
Hosseini SM; Sharifipoor F; Nazemian F; Ghanei H; Zivarifar HR; Fakharian T
Acta Med Iran; 2014; 52(4):271-4. PubMed ID: 24901856
[TBL] [Abstract][Full Text] [Related]
18. What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
Onal IK; Gokcan H; Benzer E; Bilir G; Oztas E
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):642-6. PubMed ID: 23796974
[TBL] [Abstract][Full Text] [Related]
19. Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori -resistant strains.
Fiorini G; Saracino IM; Zullo A; Gatta L; Pavoni M; Vaira D
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 29094477
[TBL] [Abstract][Full Text] [Related]
20. 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
Thong-Ngam D; Mahachai V
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S119-25. PubMed ID: 17718277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
